Tel Aviv Researchers Identify Hidden Regenerative Cell Population in the Inner Ear, Opening New Path to Hearing Restoration
Key Insights
Tel Aviv University researchers discovered a rare subset of cochlear supporting cells, termed transdifferentiating Deiters' cells (tDCs), capable of converting into sensory hair cells upon Notch (search) pathway inhibition.
The study, published in Science Advances, used live tissue imaging and single-cell multi-omics to reveal that only a distinct subpopulation of supporting cells possesses this regenerative potential, not all supporting cells uniformly.
Inhibiting the Notch (search) signaling pathway triggered these tDCs to enter a transitional state and begin transforming into hair cells, a process previously thought impossible in mature mammals.
A team at Tel Aviv University's Gray Faculty of Medical and Health Sciences has uncovered a previously hidden regenerative capacity within the mammalian inner ear, identifying a rare subpopulation of supporting cells that can transform into sensory hair cells when a key developmental signaling pathway is inhibited. The findings, published in Science Advances, challenge the long-held assumption that the adult cochlea is entirely incapable of regeneration and offer a new cellular target for future hearing loss (search) therapies.
The study was led by Prof. Karen Avraham, dean of the faculty and holder of the Dumont Chair for Research of Hearing Disorders, and spearheaded by doctoral student Lama Khalaily, in collaboration with Prof. David Sprinzak of TAU's Wise Faculty of Life Sciences, Shahar Kasirer from Sprinzak's lab, Dr. Litao Tao of Creighton University, and additional researchers.
A rare cell population with unexpected potential
Hearing loss (search) is frequently caused by damage to the cochlea's sensory hair cells, which detect sound and convert it into electrical signals transmitted to the brain. Unlike birds and fish, mammals—including humans—cannot regenerate these cells once they are destroyed, making the loss permanent. Cochlear implants and hearing aids can bypass or amplify sound but do not restore the cells themselves.
The TAU team focused on supporting cells adjacent to hair cells. "Under normal conditions, these cannot regenerate or transform into hair cells," Avraham explained. Using live tissue imaging and single-cell multi-omics methods that trace the flow of biological information within cells, the researchers discovered that the supporting cell population does not respond uniformly. Instead, only a distinct group—termed transdifferentiating Deiters' cells (tDCs)—entered a transitional state and began converting into hair cells.
These tDCs exist naturally as a kind of "reserve population" present in everyone, though Avraham noted that some individuals may naturally harbor greater regenerative potential than others.
The Notch (search) pathway as a molecular gatekeeper
To overcome the regenerative barrier, the research team inhibited the Notch (search) signaling pathway, a critical cell-to-cell communication mechanism responsible for hair cell differentiation during embryonic development. The tDCs displayed unique genetic and epigenetic characteristics—chemical switches that regulate gene expression and can be influenced by environment, lifestyle, and development—that enabled them to respond to Notch inhibition and initiate the regeneration process.
The study, titled "Live imaging and multimodal profiling reveal transdifferentiation of a cochlear supporting cell subpopulation upon Notch (search) inhibition," represents a conceptual shift in the field. Rather than searching for a single master switch, the findings point toward a more nuanced molecular recipe that activates only a specific subset of cells.
From basic research to clinical possibility
Avraham emphasized that the work remains firmly in the realm of basic science. "I want to help, but I'm careful not to raise their expectations, because it's still basic research," she said, referring to the families who regularly contact her. "But nobody else has succeeded doing what we have accomplished."
The researchers note that even five years ago, their discovery would not have been possible because the technology employed—computational 3D imaging, advanced molecular techniques, deep sequencing at multiple levels, and big-data analysis—is relatively new.
For potential future therapy, an injection could be delivered into the inner ear, though a surgeon would need to perform the procedure. The biggest scientific obstacles between this discovery and actual treatment, Avraham suggested, are regulation and cost. Because deafness involves many different genes, the associated diseases are rare, and pharmaceutical companies have shown limited willingness to invest in them.
A broader regenerative landscape
The TAU findings arrive amid growing momentum in hearing regeneration research. Parallel work by other groups has demonstrated that a combination of three transcription factors—Atoh1 (search), Gfi1 (search), and Pou4f3 (search)—can reprogram cochlear supporting cells into hair-cell-like states with increasing efficiency. Recent studies have produced nearly 2,000 regenerated hair-cell-like cells within the mouse cochlea, approaching the roughly 3,000 hair cells normally found in that organ.
Yet producing cells that resemble hair cells is not the same as restoring functional hearing. As Brandon Cox, a developmental biologist at Southern Illinois University School of Medicine, has noted, regenerated cells must develop properly organized stereocilia bundles, orient correctly within the cochlea's frequency map, and connect to the right auditory neurons. "If we have a new hair cell in a low-frequency range connected to a high-frequency neuron, it isn't going to work," Cox said.
The TAU team's identification of a specific regenerative cell subpopulation adds a critical piece to this puzzle. "Our study shows that even in tissues long considered incapable of regeneration, such as the cochlea of the inner ear, there is in fact a hidden regenerative capacity, though it is very limited and appears only in a rare subpopulation of cells," Avraham concluded. "The major challenge now is to understand how this ability can be expanded and activated in additional cells."
Future approaches may involve combinations of genetic and epigenetic interventions designed to bypass existing biological barriers, potentially opening the door to restorative treatments for a condition that currently has no curative medical solutions.